Treatment as Prevention¨

Having turned 60 two months ago, I know there’s nothing quite like a milestone birthday to force you to get serious about your priorities and your future. The HIV response is facing our own wakeup call this Dec. 1 as we mark the 30th World AIDS Day – a milestone I never imagined we would […]

New proposal would cover 5,000 PrEP prescriptions by 2019 One of the province’s most respected HIV/AIDS specialists has publicly announced that coverage for an effective HIV-prevention drug doesn’t have to cost BC taxpayers a dime. Julio Montaner, the head of the BC Centre for Excellence in HIV/AIDS, told a room full of doctors and activists

Since it was approved by the US Food and Drug Administration (FDA) in 2012, preexposure prophylaxis (PrEP) has changed the HIV prevention landscape in the United States. At the end of the first quarter of 2017, an estimated 120,000 Americans were taking emtricitabine/ tenofovir disoproxil fumarate (FTC/TDF) for PrEP. The number of new prescriptions remained

UNAIDS 90:90:90 appears to have set the course for a global ‘treatment as prevention’ strategy. In 2015 the US revised its National HIV/AIDS Strategy (NHAS) to harmonize its goals with UNAIDS 90% targets for testing, engagement in care, and virological suppression. Though the HIV/AIDS community have been nervous about the impact of the recent change

The fact that people infected with HIV who are virally suppressed cannot sexually transmit the virus to others is now accepted in the HIV/AIDS community as a result of accumulating evidence since the early 2000s. In early 2016, the Undetectable=Untransmissable (U=U) slogan was launched by the Prevention Access Campaign to promote the finding. The campaign

Diabetes Canada is adopting a diagnosis-and-treatment model of prevention pioneered by Vancouver-based AIDS researcher Dr. Julio Montaner. The approach hangs on the notion that modifiable human behaviour helps drive the spread of viruses such as HIV/AIDS and also diseases of lifestyle such as type 2 diabetes and pre-diabetes. Montaner notes that people are more likely

Bob Leahy on what words to use and what words to avoid when describing risk and ability to transmit applicable to an undetectable viral load – and why that’s important The language of HIV has evolved at an accelerated pace in recent years. It can be a struggle to keep up, to use the right

WHAT: Cardiology experts from Canada and around the world converge in Vancouver to brainstorm strategies to eradicate the impact of heart disease, showcase the latest research breakthroughs − and hear hundreds of speakers highlight innovations in science, prevention, treatment, and recovery. Congress delegates return home to their labs and practices armed with new tools and